Yüklüyor......
Early Outcomes with Durable Left Ventricular Assist Device Replacement Utilizing the Heartmate III
BACKGROUND: Heartmate III (HM3) Left Ventricular Assist Device (LVAD) (Abbott Inc, Chicago IL) is a fully magnetically levitated centrifugal implantable pump used to treat chronic heart failure patients. The MOMENTUM trial demonstrated that patients treated with the HM3 experienced reduced need for...
Kaydedildi:
| Yayımlandı: | J Thorac Cardiovasc Surg |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2019
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7325332/ https://ncbi.nlm.nih.gov/pubmed/31740114 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jtcvs.2019.09.151 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|